Vivago Oy announces appointment of new CEO
22.08.2023
Henrik Resman has been appointed as the new CEO of Vivago Oy as of 15.8.2023
Niina Vilkas will leave her position as CEO of Vivago and continue as a member of the company's Board of Directors. Following Niina Vilkas' announcement of her wish to move on to new challenges, Henrik Resman has been appointed CEO of Vivago. Henrik Resman has taken up his position on 15 August 2023.
Vivago has developed strongly in recent years. Building the company's quality system and processes, and renewing its core business, have created new opportunities in both the domestic and export markets. The Vivago Vista software has medical device approval and can be used as an aid in diagnostics and monitoring the effectiveness of care. An expanding network of partners in European countries is enabling Vivago to grow into an internationally recognised health technology player. Vivago would therefore like to collectively thank Niina Vilkas for her valuable contribution to building the company's success.
Henrik Resman has a strong background in developing international business and leading companies on an international growth path.
"It's great to be part of building Vivago into a force to be reckoned with in the global market. The good work done by Niina is a great basis for this," says Henrik Resman, commenting on the future.
Additional information:
Henrik Resman
CEO, Vivago Oy
+358 40 731 9333
[email protected]
Jukka Sonninen
Chairman of the Board, Vivago Oy
+358 40 044 6110
[email protected]
Vivago®️ develops smart solutions for preventive care monitoring and analysing user's health status and wellbeing information. Innovative solutions serve the whole care chain from home care and assisted living to rehabilitation centres and hospitals.
Vivago solutions increase the feeling of safety with automatic alarms and by providing wide range of health status information to support daily care and to follow-up the effectiveness of care. As a pioneer in health care technology, Vivago already ensures safety for tens of thousands of individuals in Europe.